Fujian Aonong Biological Technology Group Incorporation Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

You Lin Wu

Chief Executive Officer (CEO)

CN¥699.9k

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	8.8yrs
Participación del CEO	10.3%
Permanencia media de la dirección	4.5yrs
Promedio de permanencia en la Junta Directiva	5yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

You Lin Wu (45 yo)

8.8yrs

Permanencia

CN¥699,900

Compensación

Mr. You Lin Wu serves as the Chairman of the Board of Directors and General Manager at Fujian Aonong Biological Technology Group Incorporation Limited and has been its Director since August 27, 2015. Mr. W...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
You Lin Wu	Chairman of the Board of Directors & GM	no data	CN¥699.90k	10.31% CN¥ 310.4m
Huadong Huang	Vice Chairman of the Board	8.8yrs	CN¥746.60k	0.22% CN¥ 6.5m
Ze Sen Huang	Deputy GM & Financial Director	5.6yrs	CN¥629.40k	0.048% CN¥ 1.4m
Haofeng Hou	Deputy GM & Secretary to the Board of Directors	8.8yrs	CN¥761.00k	0.20% CN¥ 6.1m
Hai Feng Li	Deputy General Manager	5.6yrs	CN¥625.00k	0.10% CN¥ 3.1m
Sihu Guo	Deputy General Manager	4.5yrs	CN¥656.80k	0.035% CN¥ 1.1m
Jun Lai	Deputy General Manager	4.5yrs	CN¥705.00k	0.040% CN¥ 1.2m
Jingquan Yang	Deputy General Manager	2.6yrs	CN¥616.30k	0.016% CN¥ 494.7k
Yuanxiang Hong	Deputy General Manager	2.6yrs	CN¥749.50k	0.034% CN¥ 1.0m
Zuoming Luo	Deputy General Manager	2.6yrs	CN¥616.00k	0.012% CN¥ 363.7k
Jianping Yang	Accounting Supervisor	no data	sin datos	sin datos

4.5yrs

Permanencia media

45yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 603363 se considera experimentado (4.4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
You Lin Wu	Chairman of the Board of Directors & GM	8.8yrs	CN¥699.90k	10.31% CN¥ 310.4m
Huadong Huang	Vice Chairman of the Board	8.8yrs	CN¥746.60k	0.22% CN¥ 6.5m
Feng Liu	Independent Director	2.6yrs	CN¥120.00k	0.0033% CN¥ 99.1k
Jing Xue Zhang	Supervisor	8.8yrs	sin datos	0.27% CN¥ 8.3m
Zu Yao Huang	Vice Chairman	8.8yrs	CN¥374.10k	0.70% CN¥ 21.2m
Qing Qi Wen	Chairman of the Supervisory Board	8.8yrs	sin datos	0.28% CN¥ 8.6m
Junbiao Ye	Director	2.6yrs	CN¥745.90k	0.24% CN¥ 7.1m
Nengshui Ding	Director	5.6yrs	CN¥1.01m	0.042% CN¥ 1.3m
Junfeng Xiao	Employee Representative Supervisor	2.6yrs	sin datos	sin datos
Jun Wu	Director	4.4yrs	CN¥783.00k	0.11% CN¥ 3.3m
Luying Zheng	Independent Director	2.6yrs	CN¥120.00k	sin datos
Chunxiang Ai	Independent Director	2.6yrs	CN¥120.00k	sin datos

5.0yrs

Permanencia media

48yo

Promedio de edad

Junta con experiencia: La junta directiva de 603363 se considera experimentada (4.9 años de antigüedad promedio).

Fujian Aonong Biological Technology Group Incorporation Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Less than half of directors are independent

Fujian Aonong Biological Technology Group Incorporation Limited to Report Q1, 2024 Results on Apr 30, 2024

New minor risk - Share price stability

Fujian Aonong Biological Technology Group Incorporation Limited to Report Fiscal Year 2023 Results on Apr 30, 2024

Third quarter 2023 earnings released: CN¥0.56 loss per share (vs CN¥0.12 profit in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.71 loss per share (vs CN¥0.42 loss in 2Q 2022)

First quarter 2023 earnings released: CN¥0.21 loss per share (vs CN¥0.54 loss in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.50 loss in 3Q 2021)

Now 20% undervalued after recent price drop

First quarter 2022 earnings released: CN¥0.54 loss per share (vs CN¥0.25 profit in 1Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: CN¥0.50 loss per share (vs CN¥0.25 profit in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.54 loss per share (vs CN¥0.33 profit in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.27 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.95 (vs CN¥0.054 in FY 2019)

Investor sentiment improved over the past week

New 90-day high: CN¥15.51

Investor sentiment improved over the past week

New 90-day low: CN¥12.37

New 90-day low: CN¥13.15

New 90-day low: CN¥13.54

Fujian Aonong Biological Technology Group Incorporation Limited to Report Q3, 2020 Results on Oct 31, 2020

New 90-day low: CN¥13.63

Liu Xueke, Su Guoyang, Wu Boyuan, and Liu Lianlong agreed to acquire 21% stake in Xiamen Aomu Trade Co., Ltd from Fujian Aonong Biological Technology Group Incorporation Limited (SHSE:603363) for CNY 0.

New 90-day low - CN¥20.10

Fujian Aonong Biological Technology Group Incorporation Limited (SHSE:603363) completed the acquisition of the remaining 70% stake in Xiamen Yinxiang Meat Industry Co., Ltd. from Xiamen Yinxiang Group Co., Ltd.

New 90-day high - CN¥26.31

Earnings released

Fujian Aonong Biological Technology Group Incorporation Limited to Report First Half, 2020 Results on Aug 20, 2020

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad